Is Concordia International Corp a Buy? The Stock Rises Again

 Is Concordia International Corp a Buy? The Stock Rises Again

The stock of Concordia International Corp (TSE:CXR) is a huge mover today! The stock last traded at $4.37 per share. It is down 86.85% since March 31, 2016 and is downtrending. It has underperformed by 87.94% the S&P500.
The move comes after 9 months positive chart setup for the $218.56 million company. It was reported on Nov, 4 by Barchart.com. We have $6.42 PT which if reached, will make TSE:CXR worth $102.72M more.

Concordia International Corp (TSE:CXR) Ratings Coverage

Out of 4 analysts covering Concordia Healthcare Corp (TSE:CXR), 1 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 25% are positive. $135 is the highest target while $4.50 is the lowest. The $32.90 average target is 652.86% above today’s ($4.37) stock price. Concordia Healthcare Corp has been the topic of 23 analyst reports since August 11, 2015 according to StockzIntelligence Inc. The firm earned “Outperform” rating on Monday, May 16 by RBC Capital Markets. The stock has “” rating given by Goldman Sachs on Friday, July 22. The company was maintained on Wednesday, September 9 by Scotia Capital. The rating was downgraded by Mackie to “Hold” on Thursday, December 3. The stock has “Outperform” rating given by RBC Capital Markets on Monday, October 17. RBC Capital Markets maintained the stock with “Outperform” rating in Tuesday, October 11 report. RBC Capital Markets maintained Concordia International Corp (TSE:CXR) on Friday, January 8 with “Outperform” rating. The rating was maintained by RBC Capital Markets on Monday, October 31 with “Outperform”. The stock of Concordia International Corp (TSE:CXR) earned “Outperform” rating by RBC Capital Markets on Tuesday, June 7. The rating was maintained by RBC Capital Markets on Monday, October 24 with “Outperform”.

More notable recent Concordia International Corp (TSE:CXR) news were published by: Prnewswire.com which released: “Concordia International Corp. Announces Second Cross Currency Swap Agreement” on November 01, 2016, also Prnewswire.com with their article: “Concordia International Corp. Announces Communication With CMA” published on October 25, 2016, Prnewswire.com published: “Concordia International Corp. Announces CEO Transition Plan” on October 21, 2016. More interesting news about Concordia International Corp (TSE:CXR) were released by: Prnewswire.com and their article: “Shareholder Class Action Filed Against Concordia International Corp. – CXRX” published on August 17, 2016 as well as Business.Financialpost.com‘s news article titled: “Concordia International Corp takeover unlikely – Goldman” with publication date: September 27, 2016.

Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada pharmaceutical company. The company has a market cap of $218.56 million. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment